With a wave of FDA approvals and promising clinical trials, treatment options for metastatic breast cancer are expanding fast. Amy Tiersten, MD, highlights the power of immunotherapies—especially checkpoint…
In this video, Sarah DiGeronimo, NP, and Sydney Smith, PharmD, both from Dana-Farber Cancer Institute, Boston, Massachusetts, discuss tips for the management of common side effects resulting from…
Virtually all cervical cancers are caused by the human papillomavirus (HPV). There are more than 200 HPV subtypes and at least 13 are carcinogenic. Two subtypes, HPV 16…
Walter H. Koch, PhD, Vice President of Global Research for Roche Molecular Systems, discusses the expansion of research on Zika virus in response to last year’s outbreak.
The use of antibiotics disrupts the ecology of the microbiome in three important ways. First, antibiotic therapy can lead to secondary infection, as in antibiotic-associated diarrhea caused by…
Multiple clinical trials are currently underway examining the possible synergistic effects of combining chemotherapy with immunotherapies for patients with bladder cancer and other metastases.
James Geiger, MD, professor of surgery at University of Michigan, and his colleague, professor of engineering, Shorya Awtar, have developed a low-tech, and relatively inexpensive surgical tool that…
Probiotics can both restore and establish the microbiome after disruption by antibiotics. When the microbiome is compromised by antibiotic therapy, resulting in conditions such as antibiotic-associated diarrhea, probiotics…
Neural networks (a.k.a. deep learning algorithms) can be used to teach computers to distinguish various types of disease via prior analysis of massive amounts of clinical data.
While influenza vaccination remains the top recommendation of physicians for protecting against the flu, there are other preventive measures that still need to become more widely adopted. Many…
